Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118504) titled 'A Single-Arm, Prospective Clinical Study of Hypofractionated Thoracic Radiotherapy Combined with Adebrelimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer' on Feb. 6.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: HenanCancerHospital

Condition: Extensive-Stage Small-Cell Lung Cancer

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-03-01

Target Sample Size: Experimental Group:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=303350

Disclaimer: Curated by HT ...